Make an Impact Today
Join our mission to end pancreatic cancer by funding the most innovative research, accelerating scientific discoveries, and igniting collaboration to advance prevention, early detection and breakthrough treatments.
Inspired by the legacy of Toni Stephenson, SGPCRI strives to accelerate life-altering scientific and medical advances in pancreatic cancer to significantly reduce death rates, ease the burden on patients and their families, and ultimately eradicate the disease.
We're redefining the research landscape with a groundbreaking model designed for agility and rapid progress. Your support helps make it possible!
SGPCRI Approach
Pancreatic cancer is one of the most urgent and formidable challenges in oncology. With a devastatingly low five-year survival rate of just 13%, it is the third leading cause of cancer-related deaths globally, taking an enormous toll on individuals and families. This aggressive cancer is exceptionally difficult to detect early and remains resistant to many advanced therapies, making it one of the deadliest and most complex types of cancer. Despite its lethality, pancreatic cancer research is chronically underfunded and often fragmented, hindering the progress needed to improve outcomes and save lives. There is an immediate and critical need for innovative, collaborative and well-funded efforts to tackle this disease.
SGPCRI is redefining the research landscape with a groundbreaking model designed for agility and rapid progress. The pillars of SGPCRI include the Stephenson Global Prize, the Stephenson Global Scholar Grants and the annual Stephenson Pancreatic Cancer Symposium.